Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis

Bone Marrow Transplantation · Published 2026-08-04 · DOI 10.1038/s41409-026-02993-z

Free full text

Authors (15)

Xueyao Li, Wenhao Wang, Ruixin Li, Jieya Luo, Xin Chen, Weihua Zhai, Rongli Zhang, Jialin Wei, Donglin Yang, Yi He, Aiming Pang, Sizhou Feng, Mingzhe Han, Yigeng Cao, Erlie Jiang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, X., Wang, W., Li, R., et al. (2026). Optimal timing of letermovir prophylaxis after allogeneic hematopoietic stem cell transplantation: insights from a real-world time-varying exposure analysis. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-026-02993-z

Related articles

• Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMT · Bone Marrow Transplantation · 2026 · Same journal
• Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols · Bone Marrow Transplantation · 2026 · Same journal
• Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities · Bone Marrow Transplantation · 2026 · Same journal
• Institutional risk management for out-of-specification commercial CAR-T products · Bone Marrow Transplantation · 2026 · Same journal
• The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Data Management Group – Poster Session (P973–P983) · Bone Marrow Transplantation · 2026 · Same journal
• Vaccination in haematopoietic stem cell transplantation and cellular therapies: consensus, divergence, and uncertainties in global practice · Bone Marrow Transplantation · 2026 · Same journal
• CAR-T TEMRA and CAR-Tregs in vivo expansion are both associated with a poor response after CD19.CAR-T therapy · Bone Marrow Transplantation · 2026 · Same journal
• The 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation: Van Bekkum Awards · Bone Marrow Transplantation · 2026 · Same journal
• Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis · Bone Marrow Transplantation · 2026 · Same journal
• EASIX and sC5b-9 for early identification of adults at high risk of developing TA-TMA after allo-HCT · Bone Marrow Transplantation · 2026 · Same journal